Xenetic biosciences inc

Major-Pharmaceuticals

XBIO


99 Hayden Avenue
Lexington , MA 02421

Executive/
Director

Price

  • Last Close
  • $ 0.33
    $ -0.07 -17.5 %
    May 12, 2023
  • 52-Week High/Low
  • $0 - $0
  • YTD
  • 0%

  • Trading Volume
  • 720,788
  • Market Cap Full
  • $ 508.4K
  • Shares Outstanding
  • 1.5M
    Nov 3, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 -40.2% 5.8% 12% 18.3% -5% 6.9% -20.2% 44.1% - -
Q2 -49.4% -39.3% 82.1% 380.1% 4% -6.4% -22.2% -19.9% - -
Q3 -11.8% -26.8% -27.4% -89.1% 8% 0.5% -33% - - -
Q4 -4.4% 7.3% -34.7% 13.9% 126.7% -37.1% -46.7% - - -
J F M A M J J A S O N D
2025 - - - - - - - - - - - -
2024 - - - - - - - - - - - -
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    104%-74%-55%-15%-15%47%-37%-78%15%0%0%

Earnings

2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.02 0.34 -0.21 -6.48 -0.19 -0.15 -0.12 -0.60
Q2 5.55 0.34 -0.23 -1.56 -0.15 -0.13 -0.19 -0.69
Q3 0.28 0.26 -0.19 -2.67 -1.2 -0.13 -0.06 -0.69
Q4 0.28 - -0.17 4.35 -0.16 -0.14 -0.90 -
A 6.1 0.9 -0.8 -6.4 -1.7 -0.6 -0.5 -1.98

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 10.4 6.3 8.7 13.4 15.2
Jun 8.7 10.4 6.3 8.7 14.3 15.2
Sep 9.4 3.7 6.3 9.7 14.3 1.5
Dec 9.4 5.8 6.3 13.4 15.2 1.5
Annual

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover 2 1 - - -
Total Asset Turnover 0.1 0.1 - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage - - 4.7 - -
Equity multiplier 0.1 0.1 0.1 0.1 0.1